Venous thromboembolism in pancreatic cancer patients: Time to consider routine thromboprophylaxis?
- PMID: 36182543
- DOI: 10.1016/j.ejim.2022.09.015
Venous thromboembolism in pancreatic cancer patients: Time to consider routine thromboprophylaxis?
Conflict of interest statement
Declaration of Competing Interest MDN received honoraria for participation at advisory boards from Bayer, Daiichi Sankyo, Pfizer, Leo Pharma, Sanofi, and Viatris, outside the submitted work. NP and EP have no conflict of interest to declare.
Comment on
-
Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.Eur J Intern Med. 2022 Nov;105:30-37. doi: 10.1016/j.ejim.2022.07.020. Epub 2022 Aug 2. Eur J Intern Med. 2022. PMID: 35931614
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical